Oxford begins first human trial of Bundibugyo Ebola vaccine

The Serum Institute of India has supplied 4,000 investigational doses for the Phase I study.

source https://www.livemint.com/news/oxford-sii-first-human-trial-bundibugyo-ebola-vaccine-outbreak-public-health-emergency-screening-surveillance-11783955449271.html